Published December 27, 2016 | Version v1
Patent Open

Treatment with opioid antagonists and mTOR inhibitors

  • 1. University of Chicago

Contributors

Patent applicant:

Description

Embodiments of the invention provide methods of treating a disorder or disease characterized by cellular proliferation and migration by co-administering a synergistically effective amount of an mTOR inhibitor and a μ-opioid receptor antagonist.

Files

US20140163059.pdf

Files (1.3 MB)

Name Size Download all
md5:1bca7d3803ad95469a56748fdd0e8de2
1.3 MB Preview Download

Additional details

Identifiers

Patent number
US 201414179095 A
Patent application number
US 9526723 B2
Other
oai:uchicago.tind.io:7881

Dates

Patent filed
2014-02-12

UChicago Information

Division(s)
Biological Sciences Division
Department(s)
Anesthesia and Critical Care